See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2022_Bellicum_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001358403, Bellicum Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 49,131,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 6,712,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,311,699 |
| 9 | ResearchAndDevelopmentExpense | 1,135,655 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 359,716 |
| 12 | remainder_NetIncome | 28,358,873 |
| 13 | remainder_ComprehensiveNetIncome | -11,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 49,143,000 |
| 1 | Liabilities | 6,712,000 |
| 2 | Expenses | 3,447,354 |
| 3 | Revenues | 359,716 |
| 4 | StockholdersEquity | 42,431,000 |
| 5 | NetIncome | 25,271,235 |
| 6 | ComprehensiveNetIncome | 25,265,236 |
| 7 | BaseVar | 44,016,471 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.22 |
| 9 | EconomicCapitalRatio | 4.56 |